RNS Number : 6147C
Asimilar Group PLC
21 June 2021
 

The information contained in this announcement is deemed by the Company to constitute inside information as stipulated under the EU Market Abuse Regulation (596/2014). Upon publication of the announcement via a regulatory information service, this information is considered to be in the public domain.

21 June 2021

 

 

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

 

Exercise of 250,000 Warrants, Issue of Equity and Total Voting Rights

 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), hereby announces that the Company has received subscription notices exercising warrants to subscribe for 250,000 new ordinary shares in the Company at a subscription price of 5 pence per share (the "New Shares").

 

Application will be made for the admission of the 250,000 New Shares to trading on AIM and it is expected that dealings in the New Shares will commence on or around 25 June 2021.  On admission the New Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Total Voting Rights

Following admission of the New Shares the total issued share capital of the Company will consist of 121,683,943 Ordinary Shares, each with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

Contacts

Asimilar Group plc


John Taylor, Non-Executive Chairman

via Buchanan



Cairn Financial Advisers LLP


Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880



Peterhouse Capital Limited


Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797



Buchanan Communications Limited


Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEPPUPUQUPGGMG